<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
</head>
<body><p style="text-align:justify;"><strong>Bronchial Asthma</strong></p><p style="text-align:justify;"><span style="color:#231F20;">Asthma is a chronic inflammatory disease of the bronchial airways, which manifests as recurrent episodes of wheeze, cough, chest tightness and shortness of breath, which is usually reversible with treatment. It is characterised by increased sensitivity to many environmental agents. Asthma is variable and may be associated with seasons like the rainy season or harmattan. Bronchial asthma occurs at all ages but peaks in childhood. It is classified as an allergic disease, and may be associated with a personal or family history of allergic rhinitis (hay fever), eczema or allergic&nbsp;conjunctivitis.</span></p><p style="text-align:justify;"><span style="color:#231F20;">Complications of asthma include pneumomediastinum, pneumothorax, subcutaneous emphysema and pneumonia.</span></p><h3>&nbsp;CAUSES</h3><ul><li>&nbsp;Allergens&nbsp;e.g.&nbsp;house dust&nbsp;mite,&nbsp;cockroach droppings,&nbsp;grass,&nbsp;pollen and animal&nbsp;hair</li><li>&nbsp;Environmental factors e.g. air pollution, climatic changes, strong scents&nbsp;and&nbsp;smoke&nbsp;(including&nbsp;cigarette&nbsp;smoke&nbsp;and&nbsp;car&nbsp;fumes)</li><li>&nbsp;Viral&nbsp;infections</li><li>&nbsp;Exercise</li><li>&nbsp;Emotions and&nbsp;hyperventilation</li><li>&nbsp;Drugs&nbsp;e.g.&nbsp;aspirin,&nbsp;NSAIDS and&nbsp;beta-blockers&nbsp;such&nbsp;as&nbsp;propranolol</li><li>&nbsp;Occupational exposure to industrial chemicals, dust and drug manufacturing</li></ul><h3>SYMPTOMS</h3><ul><li>Episodic&nbsp;breathlessness</li><li>Tightness of the&nbsp;chest</li><li>Cough - often&nbsp;nocturnal</li><li>Wheeze</li><li>Nocturnal symptoms. Any of the above symptoms waking up the patient at&nbsp;night</li></ul><h3>SIGNS</h3><ul><li>Tachypnoea (fast&nbsp;breathing)</li><li>Use of accessory muscles of respiration; neck and/or abdominal muscles</li><li>Rhonchi/wheeze</li><li><strong>Signs of severe&nbsp;attack:</strong><ul><li>Inability to complete full sentences in one breath</li><li>Rapid pulse &gt; 110/minute in adults and adolescents or &gt;130/ minute in children 2-5 years</li><li>Rapid respiration &gt; 30/minute in adults and adolescents or or &gt; 50/minute in children 2-5 years</li><li>Peak Expiratory Flow Rate (PEFR) is reduced &lt; 50% of expected (for age, sex and height)</li></ul></li><li><strong>Signs of a life-threatening attack&nbsp;are:</strong><ul><li>Cyanosis</li><li>Pulsus paradoxus</li><li>Silent chest on auscultation</li><li>Drowsiness or confusion</li><li>Exhaustion</li><li>Peak&nbsp;Expiratory&nbsp;Flow&nbsp;Rate&nbsp;(PEFR)less&nbsp;than&nbsp;33&nbsp;%&nbsp;of&nbsp;expected value</li><li>SpO2 less than 92% on room&nbsp;air</li></ul></li></ul><h3>INVESTIGATIONS</h3><ul><li>No investigation required in most&nbsp;cases</li><li>FBC, mildly high eosinophil count</li><li>Chest&nbsp;X-ray&nbsp;(only for&nbsp;the&nbsp;exclusion&nbsp;of&nbsp;other&nbsp;diagnoses&nbsp;or&nbsp;complications)</li><li style="text-align:justify;">Spirometry - reduction in FEV1 and FEV1/FVC ratio with reversibility demonstrated after bronchodilator use (a normal spirometry between attacks does not exclude&nbsp;asthma).</li><li style="text-align:justify;">Tests&nbsp;for atopy - skin prick test or specific IgE for common&nbsp;allergens</li><li style="text-align:justify;">Stool examination, exclude&nbsp;helminthiasis</li></ul><h3>TREATMENT</h3><p><strong>Treatment objectives</strong></p><ul><li>To&nbsp;relieve&nbsp;bronchospasm</li><li>To&nbsp;prevent complications and&nbsp;recurrence</li><li>To&nbsp;treat underlying inflammation or&nbsp;infection</li></ul><h3>Non-pharmacological treatment</h3><ul><li>Avoid&nbsp;known&nbsp;triggers/allergens,&nbsp;such&nbsp;as&nbsp;dust&nbsp;(dust&nbsp;mite)&nbsp;where possible</li><li>Avoid smoking</li><li>Education on asthma self management, device use and&nbsp;technique</li></ul><h3>Pharmacological treatment</h3><p><span style="color:#231F20;"><strong>A.&nbsp;&nbsp;&nbsp;&nbsp; Acute Exacerbation of Asthma: Initial Management in&nbsp;the Community</strong></span></p><p><span style="color:#231F20;"><strong>Evidence Rating: [C]</strong></span></p><ul><li>Salbutamol inhaler, using pressurized metered dose inhaler (pMDI) with a&nbsp;spacer</li></ul><p><strong><u>Adults</u> and <u>Children</u></strong></p><p>Give 1-2 puffs via a spacer and mask if needed (e.g. Volumatic <strong>Or</strong></p><p>Aerochamber, or large plastic mineral water bottle) with the patient taking 3-4 breaths after each puff.</p><p>Repeat after every 15-30 minutes maximum 10 doses.</p><p>If there is no improvement seek care at a health facility with a nebuliser.</p><p><span style="color:#231F20;"><strong>B. Acute Moderate/Severe Exacerbation of Asthma:&nbsp;Initial Management in Hospital</strong></span></p><p><span style="color:#231F20;"><strong>&nbsp;1<sup>st</sup> Line Treatment Evidence Rating: [A]</strong></span></p><ul><li>Oxygen</li></ul><p>By nasal prongs 2-6 L/min</p><h3>Or</h3><p>Face&nbsp;mask&nbsp;&nbsp;&nbsp;&nbsp;4-8 L/min</p><p><strong>Or</strong></p><p style="margin-left:0in;">Non-rebreather&nbsp;mask&nbsp;&nbsp;10-15 L/min</p><h3>And</h3><ul><li>Salbutamol,&nbsp;nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>2.5-5 mg repeated initially after 15-30 minutes, then every 2-4 hours until improved</p><p><strong><u>Children</u></strong></p><p>2.5-5 mg every 2-4 hours until improved</p><p><span style="color:#231F20;"><strong>And</strong></span></p><ul><li>Ipratropium bromide,&nbsp;nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>500 microgram 4-6 hourly</p><p><strong><u>Children</u></strong></p><p>6-12&nbsp;years;&nbsp;&nbsp;250 microgram 4-6&nbsp;hourly</p><p>1-5&nbsp;years;&nbsp;&nbsp;125 microgram 4-6&nbsp;hourly (max. dose for children is 1 mg/24&nbsp;hours)</p><p><span style="color:#231F20;"><strong>And</strong></span></p><ul><li>Hydrocortisone,&nbsp;IV,</li></ul><p><strong><u>Adults</u></strong></p><p>200 mg stat. then 100 mg 6 hourly until clinical improvement</p><p><strong><u>Children</u></strong></p><p>12-18&nbsp;years;&nbsp;&nbsp;&nbsp;100 mg 6-8 hourly</p><p>1&nbsp;month-12&nbsp;years;&nbsp;&nbsp;&nbsp;2-4 mg/kg 8&nbsp;hourly</p><h3><strong>Then</strong></h3><p><span style="color:#231F20;"><strong>C. Acute&nbsp;Moderate/Severe&nbsp;Exacerbation&nbsp;of&nbsp;Asthma: Maintenance Treatment in&nbsp;Hospital</strong></span></p><p>â€¢&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Salbutamol,&nbsp;nebulised,</p><p><strong><u>Adults</u></strong></p><p>2.5-5 mg repeated every 6 hours until improved</p><p><strong><u>Children</u></strong></p><p>2.5-5 mg every 6 hours until improved</p><h3>And</h3><ul><li>Ipratropium bromide,&nbsp;nebulised,</li></ul><p><strong><u>Adults</u></strong></p><p>500 microgram 4-6 hourly</p><p><strong><u>Children</u></strong></p><p>6-12&nbsp;years;&nbsp;&nbsp;250 microgram 4-6&nbsp;hourly</p><p>1-5&nbsp;years;&nbsp;&nbsp;125 microgram 4-6&nbsp;hourly (max. dose for children 1 mg/24&nbsp;hours)</p><h3>And</h3><ul><li style="text-align:justify;">Prednisolone,&nbsp;oral,&nbsp;initial dose&nbsp;given&nbsp;on&nbsp;admission&nbsp;and&nbsp;subsequently given as a morning dose. (Once on prednisolone, stop IV hydrocortisone after 24&nbsp;hours)</li></ul><p><strong><u>Adults</u></strong></p><p>30-40&nbsp;mg&nbsp;daily&nbsp;for&nbsp;7&nbsp;days&nbsp;until&nbsp;stable. Taper&nbsp;off&nbsp;dose&nbsp;over&nbsp;a&nbsp;period of 2 weeks if patient has been on long term&nbsp;steroids.</p><p><strong><u>Children</u></strong></p><p>1-2 mg/kg for 3-5&nbsp;days</p><p><span style="color:#231F20;"><strong>D. Acute&nbsp;Moderate/Severe&nbsp;Exacerbation&nbsp;of&nbsp;Asthma: Maintenance Treatment&nbsp;in&nbsp;Hospital(where&nbsp;patient&nbsp;is&nbsp;still&nbsp;distressed&nbsp;after&nbsp;3-4 initial doses of nebulised&nbsp;salbutamol)</strong></span></p><ul><li style="text-align:justify;">Aminophylline,&nbsp;IV,</li></ul><p><strong><u>Adults</u></strong></p><p>250 mg slow injection over 20 minutes</p><p>Repeat after 30 minutes with a continuous infusion by perfusor, if necessary, at a rate not exceeding 0.5 mg/kg/hour over 24 hours</p><h3>Or</h3><ul><li>Aminophylline,&nbsp;IV&nbsp;infusion,&nbsp;250&nbsp;mg&nbsp;in&nbsp;500&nbsp;ml&nbsp;of&nbsp;5%&nbsp;Dextrose&nbsp;or&nbsp;0.9% Sodium Chloride, 6 hourly for 24&nbsp;hours</li></ul><p><strong><u>Children</u></strong></p><p>5 mg/kg over 20 minutes as a slow infusion or by perfusor at 1mg/ kg/hour (max. 500 mg)</p><p><span style="color:#231F20;"><strong>E. Chronic Asthma - Initial&nbsp;management</strong></span></p><p><span style="color:#231F20;"><strong>Evidence Rating:&nbsp;[A]</strong></span></p><ul><li>Salbutamol,&nbsp;inhaled,</li></ul><p><strong><u>Adults</u> and children</strong></p><p>100 microgram, 2 puffs as often as needed</p><h3>And</h3><p><span style="color:#231F20;">(If inhaled Salbutamol is needed more than once daily)</span></p><ul><li>Budesonide,&nbsp;inhaled,</li></ul><p><strong><u>Adults</u></strong></p><p>200 microgram (one puff 12 hourly)</p><p><strong><u>Children</u></strong></p><ul><li>10&nbsp;years;&nbsp;200 microgram (one puff 12&nbsp;hourly)</li><li>&lt;&nbsp;10&nbsp;years;&nbsp;&nbsp;100 microgram (one puff 12&nbsp;hourly)</li></ul><h3>Or</h3><ul><li>Fluticasone, Inhaled -&nbsp;MDI,</li></ul><p><strong><u>Adults</u></strong></p><p>125-250 microgram (2 puffs 12 hourly)</p><p><strong><u>Children</u></strong></p><p>50 microgram (2 puffs 12 hourly)</p><h3>Or</h3><ul><li>Beclometasone (Beclomethasone),&nbsp;inhaled,</li></ul><p><strong><u>Adults</u> and <u>Children</u></strong></p><p>100 microgram (2 puffs 12 hourly)</p><p><span style="color:#231F20;"><strong>F. Chronic Asthma - Maintenance&nbsp;treatment</strong></span></p><ul><li>Salbutamol,&nbsp;inhaled,</li></ul><p><strong><u>Adults</u> and children</strong></p><p>100 microgram, 2 puffs as often as needed</p><h3>And</h3><ul><li>Fluticasone/Salmeterol,&nbsp;inhaled,</li></ul><p><strong><u>Adults</u> and children over 5 years</strong></p><p>100/50-250/50 microgram; 1 puff 12 hourly</p><h3>Or</h3><ul><li>Budesonide/Formoterol , inhaled,</li></ul><p><strong><u>Adults</u></strong></p><p>160/4.5 microgram (1-2 puffs 12 hourly)</p><p><strong><u>Children</u> over 5 years</strong></p><p>80/4.5 microgram (1-2 puffs 12 hourly)</p><h3>And</h3><ul><li>Montelukast,&nbsp;oral,</li></ul><p><strong><u>Adult</u></strong></p><p>10 mg daily</p><p><strong><u>Children</u></strong></p><p>4 or 5 mg granules daily</p><h3>And</h3><ul><li>Prednisolone,&nbsp;oral,</li></ul><p><strong><u>Adults</u></strong></p><p>30-40 mg daily and tail down slowly over 2-3 week period to a low maintenance daily dose of 5 mg daily.</p><p><strong><u>Children</u></strong></p><p>1 mg/kg tailed off by 5 mg every third day, reducing to 5-10 mg daily or alternate daily, lowest dose possible without provoking attacks</p><h3>REFERRAL CRITERIA</h3><p style="text-align:justify;"><span style="color:#231F20;">In acute exacerbation, refer patients if not improving or rapidly deteriorating after initial management to a specialist.</span></p><p style="text-align:justify;"><span style="color:#231F20;">All discharged clients should be followed up within one week and referred to a specialist clinic for continued care.</span></p><p style="text-align:justify;"><span style="color:#231F20;">For chronic asthma refer patients with persistent symptoms to a specialist clinic in a regional or tertiary hospital, and patients who have recurrent&nbsp;acute&nbsp;exacerbations&nbsp;within a&nbsp;few&nbsp;days/&nbsp;weeks&nbsp;of&nbsp;each&nbsp;other&nbsp;for&nbsp;specialist care and review of their&nbsp;treatment.</span></p><p style="text-align:justify;"><span style="color:#231F20;">Also refer when a patient requires more than one course of oral prednisolone in 3 months.</span></p>
</body>
</html>
